Liver Disease: Monthly Essentials August 2017

Access to the full content of this site is available only to registered healthcare professionals. Register to read more
The 4 essential studies on Liver Disease this month, selected from 300 peer-reviewed studies

1. The US Food and Drug Administration has approved once-daily Vosevi for the treatment of HCV genotypes (GT) 1-6 in patients with mild or no cirrhosis. The fixed-dose combination tablet adds voxila...